Table 1. General characteristics of the study cohort in each randomised group and overall.
| ABC -> 3TC (N=6) |
3TC -> ABC (N=7) |
All (N=13) |
||
|---|---|---|---|---|
| Sex | ||||
| Male | 3 (50%) | 6 (86%) | 9 (69%) | |
| Female | 3 (50%) | 1 (14%) | 4 (31%) | |
| Ethnicity | ||||
| White | 1 (17%) | 7 (100%) | 8 (62%) | |
| Mixed or Multiple Ethnic Groups | 1 (17%) | 0 | 1 (8%) | |
| Asian | 3 (50%) | 0 | 3 (23%) | |
| Other ethnic group | 1 (17%) | 0 | 1 (8%) | |
| Genetic status | TREX1 | |||
| 1 (17%) | 2 (29%) | 3 (23%) | ||
| RNASEH2B | 3 (50%) | 2 (29%) | 5 (38%) | |
| RNASEH2C | 2 (33%) | 0 | 2 (15%) | |
| SAMHD1 | 0 | 3 (43%) | 3 (23%) | |
| JAK Inhibitors | Yes | |||
| 1 (17%) | 2 (29%) | 3 (23%) | ||
| No | 5 (83%) | 5 (71%) | 10 (77%) | |
| Age (year) | ||||
| Mean (SD) | ||||
| 8.7 (5.3) | 4.7 (2.9) | 6.5 (4.5) | ||
| Median [Q1-Q3] | 9 [5-13] | 4 [2-8] | 5 [4-9] | |
| Min Max | 1,15 | 1,9 | 1,15 | |
| N | 6 | 7 | 13 |
Numbers are n(%), mean (SD) or median [Q1-Q3]